Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Articles
You have accessRestricted Access

Renal Pathology in Fabry Disease

Joseph Alroy, Sharda Sabnis and Jeffrey B. Kopp
JASN June 2002, 13 (suppl 2) S134-S138; DOI: https://doi.org/10.1097/01.ASN.0000016684.07368.75
Joseph Alroy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharda Sabnis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey B. Kopp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 1. Renal pathology in Fabry disease. (A) Glomerulus showing extensive inclusion bodies of glycolipid in podocytes (arrowhead), and mild mesangial widening (PAS stain; magnification, ×80). (B) Plastic embedded tissue showing in-site deposition of glycolipid in glomerular podocytes (arrowhead; toluidine blue stain; magnification, ×80). (C) Plastic embedded renal tissue demonstrating glycolipid inclusion bodies in distal tubules (asterisk), with relative sparing of proximal tubules, and interstitial fibrosis (toluidine blue stain; magnification, ×80). (D) Deposition of glycolipid in endothelial cells of peritubular capillaries (asterisk; toluidine blue stain; magnification, ×200). (E) Urine showing vacuolated urinary epithelial cells (oval fat bodies) in a Fabry patient (Papanicolaou stain; magnification, ×160). Figure modified with permission from Branton et al. (14).

  • Figure2
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 2. Electron microscopy in Fabry disease. (A) Electron microscopy of a renal biopsy obtained from a 26-yr-old male Fabry patient demonstrates accumulation of storage material within the secondary lysosomes of podocytes and glomerular parietal epithelial cells. There is focal foot process effacement. There is free glycolipid in the urinary space and a thickened Bowman’s capsule (magnification, ×3760). (Inset) Higher magnification demonstrates enlarged lysosomes within a podocyte and a mixture of lamellated membrane structures and small vesicles in the glomerular parietal epithelium (magnification, ×11,200). (B) Electron microscopy of renal biopsy obtained from a male Fabry patient shows a small artery, with lysosomal storage located within endothelial cells (E) and smooth muscle cells (S) (magnification, ×3800). (Inset) Higher magnification of the endothelial cell cytoplasm demonstrates enlarged secondary lysosomes packed with storage material, which has a somewhat heterogeneous appearance (magnification, ×11,200).

PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 13 (suppl 2)
Journal of the American Society of Nephrology
Vol. 13, Issue suppl 2
1 Jun 2002
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Renal Pathology in Fabry Disease
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Renal Pathology in Fabry Disease
Joseph Alroy, Sharda Sabnis, Jeffrey B. Kopp
JASN Jun 2002, 13 (suppl 2) S134-S138; DOI: 10.1097/01.ASN.0000016684.07368.75

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Renal Pathology in Fabry Disease
Joseph Alroy, Sharda Sabnis, Jeffrey B. Kopp
JASN Jun 2002, 13 (suppl 2) S134-S138; DOI: 10.1097/01.ASN.0000016684.07368.75
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
  • Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
  • Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
Show more Articles

Cited By...

  • The Changing Landscape of Fabry Disease
  • Hydroxychloroquine-induced podocytopathy mimicking Fabry disease
  • Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy
  • Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease
  • Enzyme Replacement Therapy and Fabry Nephropathy
  • Agalsidase Alfa and Kidney Dysfunction in Fabry Disease
  • Weekly Enzyme Replacement Therapy May Slow Decline of Renal Function in Patients with Fabry Disease Who Are on Long-Term Biweekly Dosing
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire